Follow the people · Insider
Atabak Mokari
Atabak Mokari files insider transactions with the SEC as a chief financial officer of Corcept Therapeutics (CORT). We hold 4 disclosed purchases and sales filed since 29 July 2016, 3 of them in the last 90 days.
- Files forCORT
- Disclosed buys and sells4 in all, 3 in the last 90 days
- Last disclosure3 September 2026
Positions held
3 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 1 March 2021 — 2 September 2026Chief Financial Officer · Corcept Therapeutics (CORT)85 Form 4 lines · source: SEC Form 4
- Filed 19 December 2018 — 8 April 2020Chief Financial Officer · Bellicum Pharmaceuticals (BLCM)3 Form 4 lines · source: SEC Form 4
- Filed 27 July 2016 — 11 December 2018CFO and VP Corp Development · Iridex (IRIX)7 Form 4 lines · source: SEC Form 4
Everything they disclosed
95 entries, newest first — one per disclosure report, one per Form 4 line- was granted 138 shares of Corcept TherapeuticsSEC Form 43 September 2026Common Stock · traded 1 September 2026 · filed 3 September 2026
- was granted 138 shares of Corcept TherapeuticsSEC Form 43 September 2026Common Stock · traded 1 September 2026 · filed 3 September 2026
- had shares withheld for tax on 102 shares of Corcept TherapeuticsSEC Form 43 September 2026Common Stock · traded 2 September 2026 · filed 3 September 2026
- exercised options over 80,000 shares of Corcept TherapeuticsSEC Form 43 August 2026Common Stock · traded 30 July 2026 · filed 3 August 2026
- ▼ sold on the open market 7,089 shares of Corcept TherapeuticsSEC Form 43 August 2026Common Stock · traded 30 July 2026 · filed 3 August 2026
- ▼ sold on the open market 8,267 shares of Corcept TherapeuticsSEC Form 43 August 2026Common Stock · traded 30 July 2026 · filed 3 August 2026
- ▼ sold on the open market 4,783 shares of Corcept TherapeuticsSEC Form 43 August 2026Common Stock · traded 30 July 2026 · filed 3 August 2026
- ▼ sold on the open market 8,103 shares of Corcept TherapeuticsSEC Form 43 August 2026Common Stock · traded 30 July 2026 · filed 3 August 2026
- ▼ sold on the open market 1,001 shares of Corcept TherapeuticsSEC Form 43 August 2026Common Stock · traded 30 July 2026 · filed 3 August 2026
- exercised options over 80,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 43 August 2026Stock option (right to buy) · traded 30 July 2026 · filed 3 August 2026
- ▼ sold on the open market 4,200 shares of Corcept TherapeuticsSEC Form 43 August 2026Common Stock · traded 30 July 2026 · filed 3 August 2026
- ▼ sold on the open market 8,956 shares of Corcept TherapeuticsSEC Form 43 August 2026Common Stock · traded 30 July 2026 · filed 3 August 2026
- ▼ sold on the open market 400 shares of Corcept TherapeuticsSEC Form 43 August 2026Common Stock · traded 30 July 2026 · filed 3 August 2026
- ▼ sold on the open market 2,202 shares of Corcept TherapeuticsSEC Form 43 August 2026Common Stock · traded 30 July 2026 · filed 3 August 2026
- ▼ sold on the open market 600 shares of Corcept TherapeuticsSEC Form 43 August 2026Common Stock · traded 30 July 2026 · filed 3 August 2026
- ▼ sold on the open market 4,700 shares of Corcept TherapeuticsSEC Form 43 August 2026Common Stock · traded 30 July 2026 · filed 3 August 2026
- ▼ sold on the open market 15,477 shares of Corcept TherapeuticsSEC Form 43 August 2026Common Stock · traded 30 July 2026 · filed 3 August 2026
- ▼ sold on the open market 14,222 shares of Corcept TherapeuticsSEC Form 43 August 2026Common Stock · traded 30 July 2026 · filed 3 August 2026
- exercised options over 15,833 shares of Corcept TherapeuticsSEC Form 417 July 2026Common Stock · traded 15 July 2026 · filed 17 July 2026
- exercised options over 24,167 shares of Corcept TherapeuticsSEC Form 417 July 2026Common Stock · traded 15 July 2026 · filed 17 July 2026
- ▼ sold on the open market 7,919 shares of Corcept TherapeuticsSEC Form 417 July 2026Common Stock · traded 15 July 2026 · filed 17 July 2026
- ▼ sold on the open market 28,460 shares of Corcept TherapeuticsSEC Form 417 July 2026Common Stock · traded 15 July 2026 · filed 17 July 2026
- ▼ sold on the open market 3,520 shares of Corcept TherapeuticsSEC Form 417 July 2026Common Stock · traded 15 July 2026 · filed 17 July 2026
- ▼ sold on the open market 101 shares of Corcept TherapeuticsSEC Form 417 July 2026Common Stock · traded 15 July 2026 · filed 17 July 2026
- exercised options over 15,833 shares of Corcept Therapeutics (a derivative holding)SEC Form 417 July 2026Stock option (right to buy) · traded 15 July 2026 · filed 17 July 2026
- exercised options over 24,167 shares of Corcept Therapeutics (a derivative holding)SEC Form 417 July 2026Stock option (right to buy) · traded 15 July 2026 · filed 17 July 2026
- exercised options over 40,000 shares of Corcept TherapeuticsSEC Form 417 June 2026Common Stock · traded 15 June 2026 · filed 17 June 2026
- ▼ sold on the open market 9,434 shares of Corcept TherapeuticsSEC Form 417 June 2026Common Stock · traded 15 June 2026 · filed 17 June 2026
- ▼ sold on the open market 11,081 shares of Corcept TherapeuticsSEC Form 417 June 2026Common Stock · traded 15 June 2026 · filed 17 June 2026
- ▼ sold on the open market 19,483 shares of Corcept TherapeuticsSEC Form 417 June 2026Common Stock · traded 15 June 2026 · filed 17 June 2026
- ▼ sold on the open market 2 shares of Corcept TherapeuticsSEC Form 417 June 2026Common Stock · traded 15 June 2026 · filed 17 June 2026
- exercised options over 40,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 417 June 2026Stock option (right to buy) · traded 15 June 2026 · filed 17 June 2026
- exercised options over 40,000 shares of Corcept TherapeuticsSEC Form 43 June 2026Common Stock · traded 1 June 2026 · filed 3 June 2026
- ▼ sold on the open market 40,000 shares of Corcept TherapeuticsSEC Form 43 June 2026Common Stock · traded 1 June 2026 · filed 3 June 2026
- was granted 634 shares of Corcept TherapeuticsSEC Form 43 June 2026Common Stock · traded 1 June 2026 · filed 3 June 2026
- was granted 634 shares of Corcept TherapeuticsSEC Form 43 June 2026Common Stock · traded 1 June 2026 · filed 3 June 2026
- had shares withheld for tax on 395 shares of Corcept TherapeuticsSEC Form 43 June 2026Common Stock · traded 2 June 2026 · filed 3 June 2026
- exercised options over 40,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 43 June 2026Stock option (right to buy) · traded 1 June 2026 · filed 3 June 2026
- was granted 397 shares of Corcept TherapeuticsSEC Form 44 March 2026Common Stock · traded 2 March 2026 · filed 4 March 2026
- was granted 397 shares of Corcept TherapeuticsSEC Form 44 March 2026Common Stock · traded 2 March 2026 · filed 4 March 2026
- had shares withheld for tax on 96 shares of Corcept TherapeuticsSEC Form 44 March 2026Common Stock · traded 3 March 2026 · filed 4 March 2026
- was granted 397 shares of Corcept TherapeuticsSEC Form 44 March 2026Common Stock · traded 2 March 2026 · filed 4 March 2026
- was granted 397 shares of Corcept TherapeuticsSEC Form 44 March 2026Common Stock · traded 2 March 2026 · filed 4 March 2026
- had shares withheld for tax on 96 shares of Corcept TherapeuticsSEC Form 44 March 2026Common Stock · traded 3 March 2026 · filed 4 March 2026
- was granted 140,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 43 March 2026Stock Option (right to buy) · traded 27 February 2026 · filed 3 March 2026
- was granted 140,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 43 March 2026Stock Option (right to buy) · traded 27 February 2026 · filed 3 March 2026
- was granted 178 shares of Corcept TherapeuticsSEC Form 43 December 2025Common Stock · traded 1 December 2025 · filed 3 December 2025
- was granted 178 shares of Corcept TherapeuticsSEC Form 43 December 2025Common Stock · traded 1 December 2025 · filed 3 December 2025
- had shares withheld for tax on 118 shares of Corcept TherapeuticsSEC Form 43 December 2025Common Stock · traded 2 December 2025 · filed 3 December 2025
- was granted 200 shares of Corcept TherapeuticsSEC Form 44 September 2025Common Stock · traded 2 September 2025 · filed 4 September 2025
- was granted 200 shares of Corcept TherapeuticsSEC Form 44 September 2025Common Stock · traded 2 September 2025 · filed 4 September 2025
- had shares withheld for tax on 144 shares of Corcept TherapeuticsSEC Form 44 September 2025Common Stock · traded 3 September 2025 · filed 4 September 2025
- was granted 775 shares of Corcept TherapeuticsSEC Form 44 June 2025Common Stock · traded 2 June 2025 · filed 4 June 2025
- was granted 775 shares of Corcept TherapeuticsSEC Form 44 June 2025Common Stock · traded 2 June 2025 · filed 4 June 2025
- had shares withheld for tax on 519 shares of Corcept TherapeuticsSEC Form 44 June 2025Common Stock · traded 3 June 2025 · filed 4 June 2025
- was granted 140,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 44 March 2025Stock option (right to buy) · traded 28 February 2025 · filed 4 March 2025
- had shares withheld for tax on 228 shares of Corcept TherapeuticsSEC Form 44 March 2025Common Stock · traded 3 March 2025 · filed 4 March 2025
- was granted 232 shares of Corcept TherapeuticsSEC Form 44 March 2025Common Stock · traded 3 March 2025 · filed 4 March 2025
- was granted 232 shares of Corcept TherapeuticsSEC Form 44 March 2025Common Stock · traded 3 March 2025 · filed 4 March 2025
- had shares withheld for tax on 182 shares of Corcept TherapeuticsSEC Form 44 December 2024Common Stock · traded 2 December 2024 · filed 4 December 2024
- was granted 231 shares of Corcept TherapeuticsSEC Form 44 December 2024Common Stock · traded 2 December 2024 · filed 4 December 2024
- was granted 231 shares of Corcept TherapeuticsSEC Form 44 December 2024Common Stock · traded 2 December 2024 · filed 4 December 2024
- had shares withheld for tax on 143 shares of Corcept TherapeuticsSEC Form 45 September 2024Common Stock · traded 3 September 2024 · filed 5 September 2024
- was granted 400 shares of Corcept TherapeuticsSEC Form 45 September 2024Common Stock · traded 3 September 2024 · filed 5 September 2024
- was granted 400 shares of Corcept TherapeuticsSEC Form 45 September 2024Common Stock · traded 3 September 2024 · filed 5 September 2024
- had shares withheld for tax on 571 shares of Corcept TherapeuticsSEC Form 45 June 2024Common Stock · traded 3 June 2024 · filed 5 June 2024
- was granted 1,448 shares of Corcept TherapeuticsSEC Form 45 June 2024Common Stock · traded 3 June 2024 · filed 5 June 2024
- was granted 1,448 shares of Corcept TherapeuticsSEC Form 45 June 2024Common Stock · traded 3 June 2024 · filed 5 June 2024
- had shares withheld for tax on 517 shares of Corcept TherapeuticsSEC Form 45 March 2024Common Stock · traded 1 March 2024 · filed 5 March 2024
- was granted 554 shares of Corcept TherapeuticsSEC Form 45 March 2024Common Stock · traded 1 March 2024 · filed 5 March 2024
- was granted 554 shares of Corcept TherapeuticsSEC Form 45 March 2024Common Stock · traded 1 March 2024 · filed 5 March 2024
- was granted 200,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 413 February 2024Stock option (right to buy) · traded 9 February 2024 · filed 13 February 2024
- was granted 508 shares of Corcept TherapeuticsSEC Form 45 December 2023Common Stock · traded 1 December 2023 · filed 5 December 2023
- was granted 508 shares of Corcept TherapeuticsSEC Form 45 December 2023Common Stock · traded 1 December 2023 · filed 5 December 2023
- was granted 398 shares of Corcept TherapeuticsSEC Form 46 September 2023Common Stock · traded 1 September 2023 · filed 6 September 2023
- was granted 398 shares of Corcept TherapeuticsSEC Form 46 September 2023Common Stock · traded 1 September 2023 · filed 6 September 2023
- was granted 1,651 shares of Corcept TherapeuticsSEC Form 45 June 2023Common Stock · traded 1 June 2023 · filed 5 June 2023
- was granted 1,651 shares of Corcept TherapeuticsSEC Form 45 June 2023Common Stock · traded 1 June 2023 · filed 5 June 2023
- was granted 1,260 shares of Corcept TherapeuticsSEC Form 43 March 2023Common Stock · traded 1 March 2023 · filed 3 March 2023
- was granted 1,260 shares of Corcept TherapeuticsSEC Form 43 March 2023Common Stock · traded 1 March 2023 · filed 3 March 2023
- was granted 200,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 415 February 2023Stock option (right to buy) · traded 13 February 2023 · filed 15 February 2023
- was granted 793 shares of Corcept TherapeuticsSEC Form 46 September 2022Common Stock · traded 1 September 2022 · filed 6 September 2022
- was granted 793 shares of Corcept TherapeuticsSEC Form 46 September 2022Common Stock · traded 1 September 2022 · filed 6 September 2022
- was granted 100,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 411 February 2022Stock Option (Right to Buy) · traded 2 February 2022 · filed 11 February 2022
- was granted 400,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 43 March 2021Stock Option (Right to Buy) · traded 1 March 2021 · filed 3 March 2021
- was granted 21,792 shares of Bellicum Pharmaceuticals (a derivative holding)SEC Form 49 April 2020Restricted Stock Units · traded 8 April 2020 · filed 9 April 2020
- was granted 540,000 shares of Bellicum Pharmaceuticals (a derivative holding)SEC Form 44 February 2020Stock Option (right to buy) · traded 3 February 2020 · filed 4 February 2020
- was granted 300,000 shares of Bellicum Pharmaceuticals (a derivative holding)SEC Form 420 December 2018Stock Option (right to buy) · traded 19 December 2018 · filed 20 December 2018
- had shares withheld for tax on 5,833 shares of IridexSEC Form 413 December 2018Common Stock · traded 24 November 2018 · filed 13 December 2018
- had shares withheld for tax on 180 shares of IridexSEC Form 413 December 2018Common Stock · traded 11 December 2018 · filed 13 December 2018
- was granted 16,800 shares of IridexSEC Form 431 July 2018Common Stock · traded 28 July 2018 · filed 31 July 2018
- was granted 6,000 shares of IridexSEC Form 426 July 2017Common Stock · traded 24 July 2017 · filed 26 July 2017
- exercised options over 63,000 shares of Iridex (a derivative holding)SEC Form 426 July 2017Stock Option Right to Buy · traded 24 July 2017 · filed 26 July 2017
- was granted 25,000 shares of IridexSEC Form 429 July 2016Common Stock · traded 27 July 2016 · filed 29 July 2016
- was granted 40,000 shares of IridexSEC Form 429 July 2016Common Stock · traded 27 July 2016 · filed 29 July 2016
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.